Biopharma Daily Stock Updates - 02/19/21

$XBI $159.07 +2% 📈

Pipeline Updates


$DTIL +8% 3-year pre-clinical data in non-human primates shows durability and safety of ARCUS gene-editing to cut LDL cholesterol level. source


$IMCR +3% Tebentafusp granded Breakthrough Therapy Designation by FDA for unresectable or metastatic uveal melanoma. source


$INSM +1% Topline results from phase 1 study of Treprostinil Palmitil Inhalation Powder (TPIP). source


$DVAX +6% MAA approval for HEPLISAV B an adult Hepatitis B adjuvanted vaccine. source


$EOLS +72% Litigation settlement agreements to fully resolve all outstanding litigation, including the United States International Trade Commission (ITC) case regarding the sale of Jeuveau®, between the companies. A California court case filed by Medytox against Evolus will be dismissed. source


Financial Updates


$AYLA +16% $25M private offering. source



0 comments

*Disclaimer: Information provided on bpiq.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Big Movers™ is a trademark of Amp Biotech Research, LLC

©2021 by Biopharm IQ. Website by Awaken Studio.

SITE